Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study

Guidelines for the treatment of rheumatoid arthritis (RA) recommend the use of conventional synthetic disease modifying anti-rheumatic drugs (cs-DMARDs) at the onset of the disease and only in the case of therapeutic failure, the addition of a biological drug (b-DMARD) is suggested. The study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelici, Laura, Addis, Antonio, Agabiti, Nera, Kirchmayer, Ursula, Davoli, Marina, Belleudi, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133095/
https://www.ncbi.nlm.nih.gov/pubmed/34106665
http://dx.doi.org/10.1097/MD.0000000000025943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133095/
https://www.ncbi.nlm.nih.gov/pubmed/34106665
http://dx.doi.org/10.1097/MD.0000000000025943

Ejemplares similares